https://www.modernatx.com/sites/default/files/US10703789.pdfThe ink was barely dry in July 2020 when this MRNA patent came to be. It may have been 2019 when they came up with the material itself. From what I can glean, they did discover that this injected into the cell line of the DNA would in fact, lower immunity and would NOT deliver protection against cancer. In fact just how it would effect cancer might be the opposite of curing it. There seems to be NO discrepancies shown in humans and animal studies. What this tells you is that NO HUMAN STUDIES were done and from what I could see, there were LIMITED studies done on animals. This appears to be a patent based on Guess Work as opposed to conclusive evidence of just what would happen when this MRNA was introduced to DNA in the cells. There is NO trace of inconvertable healing in any way, shape or form as far as a Virus is concerned. The only concern seemed to be the ability of the MRNA to interact with the DNA. This is INCOMPREHENSIBLE that the patent itself is the MRNA and its dim result to basically mess with the DNA. It’s messaging to the cells is inconclusive. So in other words if this Patent was used to concoct, along with other inferior products made nano through technology than “Houston, WE have a Problem.” This is a DISGRACE! We might as well take the patent for DRANO and use it in pill form. I am in Disbelief at this trashy patent that is now DESTROYING HUMANS! Read it for yourselves, you cannot dress up a pig by putting lipstick on it! The Time Is Now News. click on to see small portion of the PATENT. I put The link to the whole patent into this excerpt. click on to see…

ThisaplicationisalsorelatedtoInternationalPublica generationofthefunctionalprotein,eachsteprepresentsantionNo.PCT/US2012/58519,filedOct.3,2012,entitled35oportunityforeroranddamagetothecel.Further,itis

ModifiedNucleosides,Nucleotides,andNucleicAcids,and knowntobedificulttoobtainDNAexpresionincelsasUsesThereofandInternationalPublicationNo.PCT/ DNAfrequentlyentersacelbutisnotexpresedornot

US2012/69610,filedDec.14,2012,entitledModified expresedatreasonableratesorconcentrations.ThiscanbeNucleoside,Nucleotide,andNucleicAcidCompositions. aparticularproblemwhenDNAisintroducedintoprimary

Theinstantaplicationisalsorelatedtoco-pending40 celsormodifiedcellines.aplications,eachfiledconcurentlyherewithonMar.9, Intheearly190’sBlom andcoleaguessucesfuly

2013andhavingInternationalPublicationNo.WO/2013/
1516,entitledModifiedPolynucleotidesfortheProduc rescuedvasopresin-deficientratsbyinjectinginvitro tionofBiologicsandProteinsAsociatedwithHuman transcribedvasopresinmRNAintothehypothalamus(Scihttps://www.modernatx.com/sites/default/files/US10703789.pdf

Disease;InternationalPublicationNo.WO/2013/151667, ence25:96-98;1992).However,thelowlevelsof 45

entitledModifiedPolynucleotides;InternationalPublication translationandtheimunogenicityofthemoleculesham

No.WO/2013/151663,entitledModified Polynucleotides for the Production of Membrane Proteins; International Publication No. PCT/US2013/151669, entitled Modified Polynucleotides for the Production of Cytoplasmic and

peredthedevelopmentofmRNAasatherapeuticandefortshavesincefocusedonalternativeaplicationsthatcouldinsteadexploitthesepitfals,i.e.imunizationwithmRNAs

CytoskeletalProteins;InternationalPublicationNo.PCT)50codingforcancerantigens.

OthershaveinvestigatedtheuseofmRNAtodeliveraProductionofNuclearProteins;InternationalPublication polypeptideofinterestandshownthatcertainchemicalNo.WO/2013/15164,entitledModifiedPolynucleotides modificationsofmRNAmolecules,particularlypseudouri

fortheProductionofProteins;InternationalPublicationNo. dineand5-methyl-cytosine,havereducedimmunostimula

WO/2013/15165,entitledModifiedPolynucleotidesforthe5toryefect.ProductionofProteinsAsociatedwithHuman Disease; Thesestudiesaredisclosedin,forexample,Ribostem InternationalPublicationNo.WO/2013/151671,entitled LimitedinUnitedKingdompatentaplicationserialnumber

ModifiedPolynucleotidesfortheProductionofCosmetic 0316089.2filedonJul.9,2003nowabandoned,PCT

US2013/151670,entitledModifiedPolynucleotidesforthe

ProteinsandPeptides;andInternationalPublicationNo.WO/2013/151672,entitledModifiedPolynucleotidesforthe60204publishedasW02050562,U.S.patentaplication

ProductionofOncology-RelatedProteinsandPeptides,the contentsofeachofwhicharehereinincorporatedbyrefer enceinitsentirety.

FIELD OF THE INVENTION

nationalphaseentrySer.No.10/563,897filedonJun.8, 206 publishedasUS20060247195now abandoned,and European patentaplicationnationalphaseentryserialnumberEP2004743322filedonJul.9,2004publishedas

65EP1646714nowwithdrawn;Novozymes,Inc.inPCTapliTheinventionrelatestocompositions,methods,pro cationnumberPCT/US2007/88060filedonDec.19,2007

ceses,kitsanddevicesforthedesign,preparation,manu publishedasWO200

Leave a Reply